Curaleaf Holdings (CURLF) Acquisitions (2021 - 2022)
Curaleaf Holdings (CURLF) posted quarterly Acquisitions of $92.6 million for Q4 2022, down 67.68% year-on-year from $286.5 million in Q4 2021, and up 1582.17% on a QoQ basis from $5.5 million in Q3 2022.
Curaleaf Holdings (CURLF) Acquisitions (2021 - 2022) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Acquisitions for 2 consecutive years, with $92.6 million the latest figure, recorded in Q4 2022.
- Quarterly Acquisitions fell 67.68% year-over-year to $92.6 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $119.2 million (changed N/A YoY) and the FY2025 annual result came in at $542000.0, down 88.47% from the prior year.
- Acquisitions climbed to $92.6 million in Q4 2022 per CURLF's latest filing, from $5.5 million in the prior quarter.
- Over the last five years, Acquisitions for CURLF reached as high as $286.4 million in Q4 2021 and fell as low as -$12000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 92.57 Mn |
| Sep 30, 2022 | 5.50 Mn |
| Jun 30, 2022 | 2.27 Mn |
| Mar 31, 2022 | 18.87 Mn |
| Dec 31, 2021 | 286.45 Mn |
| Sep 30, 2021 | -12,000.00 |